Stay updated with breaking news from Dermtech Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DermTech (NASDAQ:DMTK – Get Free Report)‘s stock had its “equal weight” rating reaffirmed by equities researchers at Stephens in a research note issued on Friday, Benzinga reports. They presently have a $1.50 price objective on the stock. Stephens’ price target points to a potential upside of 132.92% from the company’s previous close. Separately, BTIG Research […]
DermTech, Inc. (NASDAQ:DMTK – Get Free Report) fell 0.9% on Tuesday . The company traded as low as $0.60 and last traded at $0.61. 48,834 shares were traded during mid-day trading, a decline of 85% from the average session volume of 321,284 shares. The stock had previously closed at $0.62. Analyst Upgrades and Downgrades Separately, […]
DermTech (NASDAQ:DMTK – Get Free Report) is scheduled to post its quarterly earnings results after the market closes on Thursday, February 29th. Analysts expect DermTech to post earnings of ($0.54) per share for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link. DermTech Stock […]
DermTech, Inc. , a leader in precision dermatology enabled by a non-invasive skin genomics technology, will host a conference call and webcast on Thursday, February 29, 2024 at 5:00 p.m. Eastern...
- Ongoing emphasis on growing revenue for the DermTech Melanoma Test - Approximately $40 million in total operating expense reductions compared to fiscal 2022 resulting from all restructuring...